BlackBerry Limited announced that it has appointed Laurie Smaldone Alsup, M.D., president and chief scientific officer of PharmApprove, to the company's board of directors.
Dr. Smaldone Alsup will also serve as a member of the audit and risk management committee of the board of directors, taking over from current director Claudia Kotchka. Dr. Smaldone Alsup has 25 years of executive leadership experience in drug development, regulatory strategy, and regulatory approvals in the pharmaceutical and biotechnology industries.
